Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Bulbo-Spinal Atrophy, X-Linked × apalutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1

Conditions

Prostatic Neoplasms 5 Small Cell Lung Carcinoma 1 Prostate Adenocarcinoma 1 Patient Preference 1 Carcinoma, Small Cell 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

ostarine 1 nilutamide 1 exemestane 1 enzalutamide 1 bicalutamide 1 apalutamide 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04926181 2025-05-15

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

University of California, San Francisco

Phase 2 Terminated

2 enrolled 12 charts

GenitourinaryThoracic

Prostatic Neoplasms, Carcinoma, Small Cell, Bulbo-Spinal Atrophy, X-Linked, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡